Avidity Partners Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-195,000	Closed	-$4.58M	–	100
2024 Q2	$4.58M	Buy	+195,000	New	+$4.58M	0.19%	70